Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...
According to Stifel, the Meta partnership positions EssilorLuxottica at the forefront of the smart glasses revolution. The ...
Stifel analyst Matthew Smith raised the firm’s price target on Vital Farms (VITL) to $44 from $34 and keeps a Hold rating on the shares. The ...
Stifel Nicolaus analyst Benjamin Burnett maintained a Buy rating on Disc Medicine (IRON – Research Report) today and set a price target of ...
Plby Group Inc (PLBY) stock saw a decline, ending the day at $1.81 which represents a decrease of $-0.04 or -2.16% from the prior close of $1.85. The stock opened at $1.84 and touched a low of $1.72 ...
Thursday, January 23, 2025, marks the release of a new report by Stifel analysts on the US transport sector. The report outlines a cautious perspective on the industry's future, noting that while 2024 ...
Stifel analysts reiterated their Hold rating on Texas Instruments stock (NASDAQ:TXN) with a steady price target of $200.00.
Stifel Financial Corp. (NYSE: SF) will release its fourth quarter and full year 2024 financial results before the market ...
CEO Ron Kruszewski and Yahoo Finance Executive Editor Brian Sozzi at the 2025 World Economic Forum in Davos, Switzerland, to talk about the macro issues impacting the investment banking firm, ...
Stifel analyst Brian Brophy raised the firm’s price target on Quanta Services (PWR) to $388 from $374 and keeps a Buy rating ...
Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...
With capacity declines driving more freight market gains than demand in 2025, FedEx Freight’s spin-off and march to more ...